Skip to main content
Top

Open Access 17-06-2024 | Meeting Report

Proceedings of the Canadian Medication Appropriateness and Deprescribing Network’s 2023 National Meeting

Authors: Tiphaine Pierson, Verna Arcand, Barbara Farrell, Camille L. Gagnon, Larry Leung, Lisa M. McCarthy, Andrea L. Murphy, Nav Persaud, Lalitha Raman-Wilms, James L. Silvius, Michael A. Steinman, Cara Tannenbaum, Wade Thompson, Johanna Trimble, Cheryl A. Sadowski, Emily G. McDonald

Published in: Drug Safety

Login to get access

Excerpt

Polypharmacy, often defined as the use of five or more medications, is associated with a higher incidence of adverse drug events (ADEs) [13], and strongly linked to patient falls, cognitive impairment, hospitalizations, and death [1]. Despite these risks, polypharmacy represents a growing problem in many countries [47]. In Canada, approximately two thirds of adults over the age of 65 years take five or more prescription medications, and about a quarter (26.5%) take ten or more [8]. Factors including sex, income, and education are associated with polypharmacy, with higher rates observed in women, people of low income, and of lower education [9]. Polypharmacy is also costly, and represents an environmental burden, with medication production and disposal contributing to the healthcare sector’s carbon footprint [10, 11]. …
Appendix
Available only for authorised users
Literature
23.
go back to reference Linsky A, Zimmerman KM. Provider and system-level barriers to deprescribing: interconnected problems and solutions. Public Policy Aging Rep. 2018;28(4):129–33.CrossRef Linsky A, Zimmerman KM. Provider and system-level barriers to deprescribing: interconnected problems and solutions. Public Policy Aging Rep. 2018;28(4):129–33.CrossRef
Metadata
Title
Proceedings of the Canadian Medication Appropriateness and Deprescribing Network’s 2023 National Meeting
Authors
Tiphaine Pierson
Verna Arcand
Barbara Farrell
Camille L. Gagnon
Larry Leung
Lisa M. McCarthy
Andrea L. Murphy
Nav Persaud
Lalitha Raman-Wilms
James L. Silvius
Michael A. Steinman
Cara Tannenbaum
Wade Thompson
Johanna Trimble
Cheryl A. Sadowski
Emily G. McDonald
Publication date
17-06-2024
Publisher
Springer International Publishing
Published in
Drug Safety
Print ISSN: 0114-5916
Electronic ISSN: 1179-1942
DOI
https://doi.org/10.1007/s40264-024-01444-2